Molecular aspects of soluble guanylyl cyclase regulation

被引:51
作者
Andreopoulos, S [1 ]
Papapetropoulos, A [1 ]
机构
[1] Univ Athens, Levangelisnos Hosp, Dept Crit Care & Pulm Serv, George P Livanos Lab, GR-10675 Athens, Greece
来源
GENERAL PHARMACOLOGY-THE VASCULAR SYSTEM | 2000年 / 34卷 / 03期
关键词
cyclic guanosine monophosphate (cGMP); nitric oxide (NO); soluble guanylyl cyclase (sGC);
D O I
10.1016/S0306-3623(00)00062-8
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Soluble guanylyl cyclase (sGC) is a heterodimeric enzyme (comprised of alpha and beta subunits) that generates the intracellular second messenger cyclic guanosine monophosphate (cGMP) from guanosine triphosphate (GTP), cGMP is subsequently important for the regulation of protein kinases, ion channels, and phosphodiesterases. Since recent evidence has demonstrated that heterodimerization of the alpha/beta subunits is essential for basal and stimulated enzymatic activity, the existence of several types of isoforms for each of the two subunits, along with their varying degrees of expression in different tissues, implies that multiple regulatory mechanisms exist for sGC. Yet, progress in studying and clarifying the regulatory processes that can alter sGC expression and activity has only slowly started being elucidated In the following paper, we elaborate on sGC structure, function, and distribution along with recently described signaling pathways that modulate sGC gene expression. (C) 2000 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:147 / 157
页数:11
相关论文
共 90 条
[1]   Genetic mapping of soluble guanylyl cyclase genes - Implications for linkage to blood pressure in the Dahl rat [J].
Azam, M ;
Gupta, G ;
Chen, W ;
Wellington, S ;
Warburton, D ;
Danziger, RS .
HYPERTENSION, 1998, 32 (01) :149-154
[2]   Endothelial dysfunction in chronic myocardial infarction despite increased vascular endothelial nitric oxide synthase and soluble guanylate cyclase expression -: Role of enhanced vascular superoxide production [J].
Bauersachs, J ;
Bouloumié, A ;
Fraccarollo, D ;
Hu, K ;
Busse, R ;
Ertl, G .
CIRCULATION, 1999, 100 (03) :292-298
[3]   Generation and characterization of a stable soluble guanylate cyclase-overexpressing CHO cell line [J].
Becker, EM ;
Wunder, F ;
Kast, R ;
Robyr, C ;
Hoenicka, M ;
Gerzer, R ;
Schröder, H ;
Stasch, JP .
NITRIC OXIDE-BIOLOGY AND CHEMISTRY, 1999, 3 (01) :55-66
[4]   Expression of nitric oxide-sensitive guanylyl cyclase subunits in human corpus cavernosum [J].
Behrends, S ;
Steenpass, A ;
Porst, H ;
Scholz, H .
BIOCHEMICAL PHARMACOLOGY, 2000, 59 (06) :713-717
[5]   Assignment of GUCY1B2, the gene coding for the β2 subunit of human guanylyl cyclase to chromosomal band 13q14.3 between markers D13S168 and D13S155 [J].
Behrends, S ;
Kazmierczak, B ;
Steenpass, A ;
Knauf, B ;
Bullerdiek, J ;
Scholz, H ;
Eiberg, H .
GENOMICS, 1999, 55 (01) :126-127
[6]   A VARIANT OF THE ALPHA(2) SUBUNIT OF SOLUBLE GUANYLYL CYCLASE CONTAINS AN INSERT HOMOLOGOUS TO A REGION WITHIN ADENYLYL CYCLASES AND FUNCTIONS AS A DOMINANT-NEGATIVE PROTEIN [J].
BEHRENDS, S ;
HARTENECK, C ;
SCHULTZ, G ;
KOESLING, D .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (36) :21109-21113
[7]   Pulmonary soluble guanylate cyclase, a nitric oxide receptor, is increased during the perinatal period [J].
Bloch, KD ;
Filippov, G ;
Sanchez, LS ;
Nakane, M ;
DelaMonte, SM .
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, 1997, 272 (03) :L400-L406
[8]   Tissue distribution of the human soluble guanylate cyclases [J].
Budworth, J ;
Meillerais, S ;
Charles, L ;
Powell, K .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1999, 263 (03) :696-701
[9]   EXPRESSION OF SOLUBLE GUANYLATE-CYCLASE ACTIVITY REQUIRES BOTH ENZYME SUBUNITS [J].
BUECHLER, WA ;
NAKANE, M ;
MURAD, F .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1991, 174 (01) :351-357
[10]   Characterization of the soluble guanylyl cyclase β-subunit gene in the mosquito Anopheles gambiae [J].
Caccone, A ;
García, BA ;
Mathiopoulos, KD ;
Min, GS ;
Moriyama, EN ;
Powell, JR .
INSECT MOLECULAR BIOLOGY, 1999, 8 (01) :23-30